Zimbabwe became first in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
Monoclonal antibody prevented Malaria infection in African adults
On Oct. 31, 2022, the National Institutes of Health announced that a clinical trial had found that one…
Japan approved partial change to a NDA for Omicron-targeting bivalent booster COVID-19 vaccine
On Oct. 31, 2022, Moderna announced that it had received approval from the Ministry of Health, Labour and…
Abbott’s FreeStyle Libreﾮ was named Best Medical Technology in Last 50 Years by the Galien Foundation
On Sept. 3, 2014, the Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,…
Reported cancer deaths continued downward trend; modest improvements in survival for pancreatic cancer
On Oct. 27, 2022, the National Institutes of Health announced that overall cancer death rates continued to decline…
Tuberculosis deaths and disease increased during the COVID-19 pandemic
On Oct. 27, 2022, the World Health Organization reported that an estimated 10.6 million people fell ill with…
NIH awarded USC $11.7 million to develop implantable devices for the nervous system
On Oct. 26, 2022, the NIH announced it had awarded the University of Southern California (USC) $11.7 million…
University of Washington reported global COVID cases will increase in coming months, but at a slower pace
On Oct. 25, 2022, the University of Washington reported that daily global COVID-19 infections were projected to rise…
NIH awarded University of Missouri $8 million grant to expand National Swine Resource and Research Center
On Oct. 25, 2022, the National Institutes of Health (NIH) announced that the University of Missouri had been…
EC expanded Merckﾒs VAXNEUVANCEﾙ indication to include infants, children and adolescents
On Oct. 24, 2022, Merck announced that the European Commission had approved an expanded indication for VAXNEUVANCEﾙ (Pneumococcal…
Study confirmed safety of shingles vaccine
On Oct. 20, 2022, newly published results supported previous findings that the recombinant zoster vaccine Shingrix, recommended by…
U.S. FDA recommended Novavax COVID-19 vaccine, adjuvanted as a booster in adults
On Oct. 19, 2022, the U.S. FDA recommended the use of the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) as…
EMA’s CHMP for Human Use issued positive opinion recommending authorization for use of Spikevax in children 6 months – 5 years in EU
On Oct. 19, 2022, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
Pfizer and BioNTech received positive CHMP ppinion for COMIRNATYﾮ in children 6 months to less than 5 lears in EU
On Oct. 19, 2022, Pfizer and BioNTech announced that the European Medicines Agencyﾒs (EMA) Committee for Medicinal Products…
Global leaders committed US$ 2.6 billion at World Health Summit to end polio
On Oct. 18, 2022, global leaders confirmed US$ 2.6 billion in funding toward the Global Polio Eradication Initiativeﾒs…
Moderna announced supply agreement with Gavi that secured access to updated variant-specific COVID-19 vaccines for low-and-middle income countries
On Oct. 17, 2022, Moderna and Gavi, the Vaccine Alliance, have mutually agreed to cancel remaining pending orders…
DNA evidence of plague found in Central Asia
On Oct. 15, 2022, scientists reported that DNA evidence showed that the plague infection was endemic in the…
Novavax COVID-19-influenza combination vaccine candidate induced antibody and T-Cell responses against SARS-CoV-2 and influenza
On Oct. 13, 2022, Novavax announced positive results from the Phase 1/2 clinical trial of its COVID-19-Influenza Combination…
Gene associated with better immune response and protection after COVID-19 vaccination identified by Oxford researchers
On Oct. 13, 2022, researchers from the University of Oxford reported findings from a study exploring how certain…
Chinese medical writings recorded decreases in goiter size upon ingestion of seaweed (iodine)
Early Chinese medical writings in approximately 3600 B.C. were the first to record the decreases in goiter size…
Moderna received Authorization for Emergency Use from FDA of Omicron-targeting bivalent COVID-19 booster vaccine for children
On Oct. 12, 2022, Moderna announced that it had received emergency use authorization from the U.S. Food and…
Researchers developed method to study brain connectivity, functionality
On Oct. 12, 2022, scientists announced they had developed a research method that allows for a much more…
Roche launched next-generation portfolio of SARS-CoV-2 rapid antigen tests
On Oct. 11, 2022, Roche announced the launch of its next-generation portfolio SARS-CoV-2 rapid antigen tests (ﾓ2.0ﾔ) for…
Intranasal COVID-19 vaccine candidateﾒs clinical data highlighted need for further development of nasal spray vaccines
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
Novavax and SK bioscience filed post approval change application in South Korea for Nuvaxovidﾙ COVID-19 vaccine as booster in adults
On Oct. 10, 2022, Novavax announced that partner, SK bioscience, had submitted a Post Approval Change Application to…
FDA approved vaccine for use during third trimester of pregnancy to prevent whooping cough in infants
On Oct. 7, 2022, the U.S. Food and Drug Administration approved Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and…
FDA authorized Monkeypox test
On Oct. 7, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorizationto Abbott Molecular, Inc.,…
3D map revealed DNA organization within human retina cells
On Oct. 7, 2022, the National Eye Institute researchers announced they had mapped the organization of human retinal…
USDA confirmed highly pathogenic Avian influenza in commercial chickens in Arkansas
On Oct. 7, 2022, the U.S. Department of Agricultureﾒs Animal Plant Health Inspection Service confirmed the presence of…
Merck and Ridgeback Biotherapeutics provided update on new clinical and non-clinical studies of LAGEVRIOﾙ (molnupiravir)
On Oct. 6, 2022, Merck announced data from two real-world evidence studies evaluating LAGEVRIOﾙ (molnupiravir), an investigational oral…